Загрузка...
Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma
BACKGROUND: We report a phase I study to examine the pharmacokinetics, safety, and recommended dosage of weekly intravenous bolus 5-fluorouracil (5-FU) in children and young adults with recurrent ependymoma. METHODS: Patients 22 years of age or less with recurrent ependymoma were treated with bolus...
Сохранить в:
| Опубликовано в: : | Neuro Oncol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633933/ https://ncbi.nlm.nih.gov/pubmed/26541630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov181 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|